封面
市场调查报告书
商品编码
1410784

神经血管血栓切除装置市场:市场规模(按细分市场)、份额、监管、报销、程序、预测(~2033)

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

神经血管血栓切除装置用于在急性缺血性中风期间移除神经血管内的血块。有两种类型:支架回收器和吸引导管。这些仪器可以单独使用,也可以组合使用。支架回收器和抽吸导管可以单独使用,也可以结合使用,具有可比较的临床结果和血管重建率。

该报告深入探讨了全球神经血管血栓切除装置市场,提供竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。

目录

目前市面上的神经血管取栓设备及竞争状况

  • 洞察关键产业趋势
  • 2015年至2033年神经血管血栓切除装置各细分市场的市场总收入及市场前景
  • 有关单位、平均售价和市场价值的详细数据

全球、区域和国家见解

  • 神经血管血栓切除设备市场的SWOT分析
  • 神经血管血栓切除设备市场的竞争动态洞察与趋势
  • 按国家/地区划分的医疗保健系统概览
  • 各国报销政策
  • 各国医疗技术法规现状

Abstract

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Neurovascular Thrombectomy Devices market for the year 2020 and beyond. Neurovascular thrombectomy devices are used for the removal of a blood clot in the neurovascular vessels during an acute ischemic stroke. The two types of devices are stent retrievers and aspiration catheters. These devices can be used individually or in combination. While the clinical outcomes and revascularization rates is similar for both the device, used separately or in conjugation, the aspiration retriever is quicker and easier to operate and is therefore becoming more popular.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Thrombectomy Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Neurovascular Thrombectomy Devices market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Neurovascular Thrombectomy Devices market.
  • Competitive dynamics insights and trends provided for Neurovascular Thrombectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Cerenovus, Medtronic Plc, Phenox GmbH, MicroVention Inc, Stryker Corp, Imperative Care Inc, Rapid Medical, Penumbra Inc, Balt SAS, Acandis GmbH & Co KG and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Neurovascular Thrombectomy Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Neurovascular Thrombectomy Devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Neurovascular Thrombectomy Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Thrombectomy Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Neurovascular Thrombectomy Devices market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable